US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by ResMed Inc.

News headline image
ResMed’s Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2025
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
ResMed Announces Participation in the UBS Global Healthcare Conference
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
UPDATE -- ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
ResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock Exchange
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
Vaping Expected to Increase COPD Health and Economic Burden by 2050
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader Christopher DelOrefice to its Board
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
ResMed to Report Fourth Quarter Fiscal 2024 Earnings on August 1, 2024
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
ResMed Announces Participation in the RBCCM Global Healthcare Conference
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep Apnea
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD
News headline image
ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference
From ResMed Inc.
Via GlobeNewswire
Tickers ASX:RMD RMD